Brief: MindWalk Announces B Cell Llama™, A Nanobody Discovery Platform Designed For The Bispecific And Cell Therapy Era
06/03/2026 21:03
March 6 (Reuters) - MindWalk Holdings Corp HYFT.O: MINDWALK ANNOUNCES B CELL LLAMA™, A NANOBODY DISCOVERY PLATFORM DESIGNED FOR THE BISPECIFIC AND CELL THERAPY ERA Source text: ID:nBw7XQBdta Further company coverage: HYFT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai